Related Experiment Video

Updated: Mar 3, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

19.6K

Bitter Melon Enhances Natural Killer-Mediated Toxicity against Head and Neck Cancer Cells

Sourav Bhattacharya1, Naoshad Muhammad1, Robert Steele1

  • 1Department of Pathology, Saint Louis University, St. Louis, Missouri.

Cancer Prevention Research (Philadelphia, Pa.)
|May 4, 2017
PubMed

Insights

Bitter melon extract (BME) enhances natural killer (NK) cell activity against head and neck squamous cell carcinoma (HNSCC). This study shows BME boosts NK-cell-mediated tumor killing, suggesting a role in cancer immunotherapy.

Area of Science:

  • Immunology
  • Oncology
  • Natural Products

Background:

  • Natural killer (NK) cells are crucial for innate immunity and antitumor responses.
  • The role of NK cells in solid tumor growth control is under investigation.
  • Bitter melon extract (BME) has been shown to modulate regulatory T cells in head and neck squamous cell carcinoma (HNSCC).

Purpose of the Study:

  • To investigate the effect of BME on NK-cell-mediated killing of HNSCC cells.
  • To determine if BME enhances the cytotoxic activity of NK cells against HNSCC.

Main Methods:

  • Treatment of human NK-cell line (NK3.3) with BME.
  • Co-culture of BME-treated NK3.3 cells with HNSCC cells.
  • Analysis of NK cell degranulation markers (granzyme B, CD107a/LAMP1) and surface receptors (CD16, NKp30).

Main Results:

  • BME treatment significantly enhanced the ability of NK3.3 cells to kill HNSCC cells.
  • BME increased granzyme B accumulation and CD107a/LAMP1 translocation in NK3.3 cells.
  • BME-treated NK3.3 cells exhibited increased surface expression of CD16 and NKp30 when co-cultured with HNSCC cells.

Conclusions:

  • Bitter melon extract augments NK-cell-mediated killing activity against HNSCC.
  • BME demonstrates an immunomodulatory role in enhancing NK cell function.
  • These findings suggest BME as a potential therapeutic agent for HNSCC immunotherapy.

More Related Videos

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity06:08

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity

Published on: August 9, 2017

25.3K
Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line11:02

Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line

Published on: February 8, 2022

6.5K

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
691
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.8K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
9.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K